BCL6 and breast cancer: In conclusion, our current study demonstrated that the reduced miR-339-5p expression [our previous data (ref)] promoted BCL6 expression, which in turn induces cyclinD1 and CXCR4 expression for induction of breast cancer cell proliferation and invasion.